4/A
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-19-035852
Options or other derivatives
- Chief Business Officer acquired 240,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Sniecinski Megan · Chief Business Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-12-17 | Grant or award : show line 1 in the form Emp. Stock Option (Right to Buy) | +240,000 | 240,000 | D |
Loading xslF345X03/form4a.xml…